Home | Curriculum Vitae | Publications | Patient Guides | Research Interests | Charitable Links | Emerging Technologies | Contact
 
Francis Chinegwundoh - Publications
 MBBS MS FRCS (Eng & Ed) FRCS(Urol) FEBU

  • Rayter Z, Chinegwundoh F. An unusual case of omental hernia. Postgraduate Medical Journal 1990 66: 682-683.

  • Chinegwundoh FI. The disappearing fax. British Journal of Hospital Medicine 1991 45:199

  • Chinegwundoh FI, Gough AC, Kaisary AV, Smith DCA, Wolf RC, Spurr NK. Debrisoquine metaboliser status as a risk factor for bladder cancer (abstract) European Urology, 1992, p.254.

  • Chinegwundoh FI, Gough AC, Kaisary AV, Smith DCA, Wolf RC, Spurr NK. Debrisoquine metaboliser status as a risk factor for bladder cancer. Urology 1992 pages 383-386. ed. Giuliani L, Puppo P. publ. Monduzzi Editore.

  • Chinegwundoh FI. Genoa: BPH discussion , prostate screening and ileal segment bladders. Hospital Update 1993 19:14

  • Chinegwundoh FI. Urology Update. Hospital Update 1993 19:614

  • Chinegwundoh FI, Gough AC, Kaisary AV, Smith DCA, Wolf RC, Spurr NK. Metabolic oxidative status - a predictor of bladder cancer? The Journal of Urology (abstracts) 1993 4:484A

  • Farrar D, Chinegwundoh FI. Urinary Tract Infections. Surgery 1994 12:5, 104-110

  • Chinegwundoh FI, Ryan P, Luesley T, Chan S. Renal and diaphragmatic endometriosis de novo associated with hormone replacement therapy. J Urol 1995 153: 380-381.

  • Chinegwundoh FI, Kaisary AV. Smoking, bladder cancer and metabolic oxidation. The Journal of Urology, Abstracts from the American Urological Association Meeting, May 1994

  • Chinegwundoh FI. Update on Urology. Hospital Update 1994 20: 423

  • Chinegwundoh FI, Nayeem N. Experience of Burch colposuspension in a District General Hospital. Br J Clin Prac. 1995 49:41-44

  • Chinegwundoh FI. Recurrent testicular torsion. B J Urol. 1995 76:268

  • Chinegwundoh FI, Kirkham JS. Two cases of volvulus of the stomach associated with colon in the chest. Br J Clin Prac. 1995 49:152-153

  • Farrar D, Chinegwundoh FI. How should I deal with recurrent urinary tract infection in women. Medicine in Practice 1995 2:11

  • Spurr N, Chinegwundoh FI, Gough A, Smith D. Poymorphisms in drug metabolising enzymes as modifiers of cancer risk. Clinical Chemistry 1995 41:1864-9

  • Chinegwundoh FI. The post traumatic painful testis. J Roy Soc Med 1996 72:291
  • Chinegwundoh FI, French M, Warfield A. Metastatic ureteral tumour. Urologia Internationalis 1996 56:55-56

  • Chinegwundoh FI, Kaisary AV. Smoking and polymorphism in bladder cancer. B J Urol 1996 77:672-675

  • Chinegwundoh FI. The early history of bladder cancer. Abstract in the American Urological Association Meeting book Florida 1996

  • Chinegwundoh FI. Genetic polymorphism and bladder cancer. European Urology Abstracts 1996: Vol.30, supplement 2, abstract 286

  • Chinegwundoh FI. Causes of readmission following prostatectomy. European Urology Abstracts 1996: Vol.30, supplement 2, abstract 352

  • Chinegwundoh FI. Glutathione s-transferases - responsible for chemoresistance? European Urology Abstracts 1996: Vol.30, supplement 2, abstract 782

  • Chinegwundoh FI. The early history of bladder cancer. European Urology Abstracts 1996: Vol.30, supplement 2, abstract 1047

  • Chinegwundoh FI, Khor T, Leedham P. Bladder metastasis from renal cell carcinoma BJUrol 1997, 79(4): 650-651

  • Chinegwundoh F I. Letter in the BMJ. December 1997. Surgical waiting lists
  • Chinegwundoh F. I. The Early (Surgical) History of Bladder Cancer. In De Historia Urologiae Europaeae volume 4, 1997. Publ. Historical Committee European Association of Urology

  • Chinegwundoh FI. Prostate Cancer. Review article in CME Bulletin Geriatric Medicine. 1998; 1 (3); 75-77

  • Chinegwundoh F, Oliver T, Farrugia D, Ansell W, Grant-Williams G. Intermittent hormone therapy in advanced prostate cancer. Eur Urol 1999:35 (suppl 2); 1-196, abstr 47

  • Chinegwundoh F, Liyanage G, Oliver T. Screening African-Caribbean versus Caucasian Prostate Cancers for markers of enhanced malignancy. Eur Urol 1999:35 (suppl 2); 1-196, abstr 583

  • Torabi-Pour N, Nouri AME, Chinegwundoh F, Oliver RTD. Standardisation and Potential Use of HPLC for Detection of Cellular Placental Alkaline Phosphatase Using Established Tumour Cell Lines and Fresh Bladder Biopsies. Urol. Int 1999;63:234-241

  • Farrugia D, Ansell W, Singh M, Philp T, Chinegwundoh F, Oliver RTD. Stilboestrol plus adrenal suppression as salvage treatment for patients failing treatment with luteinizing hormone-releasing hormone analogues and orchidectomy. BJU International 2000; 85:1069-73

  • Feneley MR, Jan H, Granowski M, Mather SJ, Ellison D, Glass J, Coptcoat M, Kirby RS, Ogden C, Oliver RTD, Badenoch DF, Chinegwundoh FI, Nargund VH, Paris AMI, Britton KE. Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer. Prostate Cancer and Prostatic Diseases 2000; 3(1): 47-52

  • Iles RS, Right M, Price K, Otite O, Chinegwundoh F, Persad R. Fetal antigen 2 (FA-2) a new serum marker for the detection and monitoring of patients with bone metastases. Prostate Cancer 2000; 3 (2) poster abstracts p.124

  • Oliver RTD, Farrugia D, Ansell W, Chinegwundoh F. Potential of intermittent hormone therapy for M+ and M0 prostate cancer patients. Prostate Cancer and Prostatic Diseases 2000; 3, 1-4

  • Enver MK, Chinegwundoh F, Hoh I. Aspirin and transurethral resection of the prostate. European Urology (supplememts 1) 2002, No.1,abstr. 674

  • Chinegwundoh F. Prostate cancer: an update. Caribbean Health 2001; 4 (6): 6-7

  • Oliver RTD, Lane T, Wells P, Chinegwundoh F, Nargund V. Medical interventions relevant in prevention and management of early prostate cancer: a new potential role for GPs, schools' and works' medical officers, as well as STD, family planning and infertility clinics. Chapter 8 in The Effective management of prostate cancer. Edited by Wallace, Oliver, Ash, Miles. Published by Aesculapius medical press, 2002

  • Chinegwundoh F I. Prostate cancer in ethnic minorities. Men's health journal, 2003:2 (issue 3); 95-97

    •

  • Chinegwundoh F I, Enver M K, Lee A, Ben-Shlomo Y, Kapoor S, Pati J. Increased risk of prostate cancer in UK African Caribbean immigrants. BJU International, 2003;91, supplement 2, abstract 79

  • Lane TM, Berney D, Chinegwundoh F, Hines J, Philp T, Corr J, Oliver T. CGH-based microarrays in the analysis of prostate cancer progression from high grade PIN (hgPIN) to hormone resistant and metastatic disease. J Urol. 2003; 169(4):58-58 (abstract)

  • Steggall M, Gann Y, Chinegwundoh F. Sexual dysfunction screening: the advantages of a culturally sensitive joint assessment clinic. Sexual and Relationship Therapy, 2004; 19:179-189

  • Lane TM Ansell W Farrugia D Wilson P Williams G Chinegwundoh F Philp T Hines J Oliver RT
    Long-term outcomes in patients with prostate cancer managed with intermittent androgen suppression.
    Urol Int 2004 ; 73: 117-22 [abstract]

  • Chinegwundoh F, Anie KA. Treatments for priapism in boys and men with sickle cell disease (Cochrane Review).
    In: The Cochrane Library, Issue 4, 2004. Chichester, UK: John Wiley & Sons, Ltd. [abstract]

  • Mohamed K. Enver, Paul D. Miller, Frank I. Chinegwundoh. Upper tract surveillance in primary bladder cancer follow-up
    BJU International Vol. 94 Issue 6 Page 790 October 2004

  • Thiagarajan Nambirajan, Syed Aslam Sohaib, Christopher Muller-Pollard, Rodney Reznek, Frank I. Chinegwundoh. Virtual cystoscopy from computed tomography: a pilot study
    BJU International Vol. 94 Issue 6 Page 828 October 2004 [abstract]

  • Chinegwundoh F, Lee A, Radhakrishnan S, Hines J, Hill J, Oliver RTD.  Immediate verus deferred radiation for patients       receiving intermittent hormone therapy for locally advanced prostate cancer. Br J Urology International, 2005;95, supplement 5, abstract 124, page 91  

    •

  • Thwaini A, Shergill I, Radhakrishnan S, Chinegwundoh F, Thwaini H. Botox in urology. Int Urogynecol J pelvic floor dysfunction. 2005 Nov;19:1-5 [abstract]

  • Steggall M, Gann S, Chinegwundoh F. Erectile dysfunction and management at an East London Clinic. J Diabetes Nursing. October 2005

  • Ghani K, Rockall A, Nargund V, Chinegwundoh F.  Prostate biopsy: to stop anticoagulation or not?  BJU Int. 2006 Feb; 97:22-225                                                                                                                                                                   

  • Enver MK, Hoh I, Chinegwundoh F. The management of aspirin in transurethral prostatectomy:current practice in the UK. Ann R Coll Surg Engl 2006; 88:280-283 [abstract]

  • Reichle J, Turk S, Chinegwundoh F, Buchholz N. Prostate stents as ultima ratio in unfit patients. Indian J Urology 2006; 22:68-70

  • Chinegwundoh F, Enver M, Lee A, Nargund V, Oliver T. Risk and presenting features of prostate cancer amongst African-Caribbean, South Asian and European men in North-East London. BJU Int. 2006 Dec. 98:1216-1220 [abstract]

  • Ghani K, Chinegwundoh F. The urological management of the patient with acquired immunodeficiency syndrome. BJU Int 2006, 98(3):689-690 [letter]

  • Chinegwundoh F. Management of male stress incontinence. Trends in urology, gynaecology & sexual health 2006; 11(5):12-14 [full text]

  • Stegall M, Gann S, Chinegwundoh F. Management of erectile dysfunction and performance anxiety. Trends in urology, gynaecology & sexual health 2006; 11(5):32-36 [abstract]

  • Otite U, Baithun S, Chinegwundoh F, Nargund V, Iles R. Detection of human chorionic gonadotrophin-β in serum or urine of prostate cancer patients is of no clinical significance. Tumour Biology 2006; 27:181-186 [abstract]

  • Thwaini A, Naase M, Chinegwundoh F, Ghali L, Shergill I, Iles R. Gonadotropins and prostate cancer -revisited. Urologia Internationalis 2006; 77:289-296 [abstract]

  • Stegall M J, Butler J, Coals S, Chinegwundoh F. Heart disease and erectile dysfunction: management at a nurse led clinic. British Journal of Cardiac Nursing 2006, 1 (12):596-601

  • Radhakrishnan S, Lee A, Enver K, Thwaini A, Chinegwundoh F. Impact of race on biochemical control after radiotherapy for localised and locally advanced prostate cancer. Prostate cancer and prostatic diseases 2006;9: abstract on p467

  • Thwaini A, Ghali L, Baithun S, Chinegwundoh F, Ahmed R, Elterifi I, Morgan D, Iles R. HCB beta as a prognostic marker in adenocarcinoma of the prostate in men of multi-ethnic origins. Urology 2006, 68,supplement 5A: p97 abstract MP-08.05

  • Thwaini A, Naase M, Chinegwundoh F, Baithun S, Ahmed R, Morgan D, Richard L, Iles R.  The association between genetic variant of luteinizing hormone and the incidence and prognosis of prostate cancer in groups of multi-ethnic origin. Urology 2006, 68, supplement 5A: p259 abstract UP-02.27

  • Radhakrishnan S, Lee A, Oliver T, Chinegwundoh F. An infectious cause for prostate cancer. BJU Int. 2007 Feb. 99(2):239-240

  • Ben-Shlomo Y, Evans S, Metcalfe C, Ibrahim F, Patel B, Gillatt D, Anson K, Corbishley C, Kirby R, Muir G, Chinegwundoh F, Nargund V, Dorling D, Thomas B, Persad R.  The risk of prostate cancer amongst black men in the United Kingdom:the PROCESS cohort study.  European Urology supplement 2007; 6(2):176 abstract no. 616

 

 

 

 

 

 

 

 

 

 

 

 
Designed by Medical Media